Geron GERN
NASDAQ GERN
$1.38 -0.02 (-1.78%)
As of: Sep 10, 2026 · 3:59 PM EDT

Geron (GERN) Capital Expenditures (2010 - 2024)

Geron's (GERN) quarterly Capital Expenditures came in at -$141000.0 in Q4 2024, down 320.31% year-over-year from $64000.0 in Q1 2024, and down 7150.0% quarter-over-quarter from $2000.0 in Q2 2024.

Analysis

Geron (GERN) Capital Expenditures (2010 - 2024) Analysis & Trends

Geron has disclosed Capital Expenditures across 15 years of filings, most recently posting -$141000.0 for Q4 2024.

  • In Q4 2024, Capital Expenditures fell 320.31% year-over-year to -$141000.0; the TTM figure through Dec 2024 stood at $680000.0 (down 18.07% YoY), while the FY2024 annual figure was $680000.0, down 18.07% from the prior year.
  • Capital Expenditures came in at -$141000.0 for Q4 2024 at Geron, down from $2000.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $19.0 million in Q3 2022 to a low of -$24.1 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $134157.9, with a median of $2000.0 recorded in 2024.
  • The largest YoY upside for Capital Expenditures was 5818.69% in 2022 against a maximum downside of 662.83% in 2022.
  • Over 5 years, Capital Expenditures stood at -$2.2 million in 2020, then sank by 45.98% to -$3.2 million in 2021, then slumped by 662.83% to -$24.1 million in 2022, then surged by 100.27% to $64000.0 in 2023, then plunged by 320.31% to -$141000.0 in 2024.
  • Per Business Quant data, the three most recent Capital Expenditures figures were -$141000.0 in Q4 2024, $2000.0 in Q2 2024, and $819000.0 in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 513.00 Mn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 140.00 Mn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn 112.20 Mn
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 240.20 Mn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 37.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn 34.68 Mn
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 40.90 Mn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -1.87 Mn
10 Geron 914.60 Mn 613.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -141,000.00
Jun 30, 2024 2,000.00
Mar 31, 2024 819,000.00
Dec 31, 2023 64,000.00
Sep 30, 2023 192,000.00
Jun 30, 2023 2.49 Mn
Mar 31, 2023 -1.92 Mn
Dec 31, 2022 -24.08 Mn
Sep 30, 2022 19.00 Mn
Jun 30, 2022 -1.79 Mn
Mar 31, 2022 7.29 Mn
Dec 31, 2021 -3.16 Mn
Sep 30, 2021 321,000.00
Jun 30, 2021 -715,000.00
Mar 31, 2021 3.76 Mn
Dec 31, 2020 -2.16 Mn
Sep 30, 2020 2.95 Mn
Jun 30, 2020 -140,000.00
Mar 31, 2020 -249,000.00
Dec 31, 2019 -986,000.00